Your browser doesn't support javascript.
loading
Reply to J. Richter et al.
Rousselot, Philippe; Charbonnier, Aude; Cony-Makhoul, Pascale; Agape, Philippe; Nicolini, Franck E; Varet, Bruno; Gardembas, Martine; Etienne, Gabriel; Réa, Delphine; Roy, Lydia; Escoffre-Barbe, Martine; Guerci-Bresler, Agnès; Tulliez, Michel; Prost, Stéphane; Spentchian, Marc; Cayuela, Jean Michel; Reiffers, Josy; Chomel, Jean Claude; Turhan, Ali; Guilhot, Joëlle; Guilhot, François; Mahon, François-Xavier.
Afiliação
  • Rousselot P; Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles, France phrousselot@ch-versailles.fr.
  • Charbonnier A; Institut Paoli Calmette, Marseille, France.
  • Cony-Makhoul P; Hôpital d'Annecy, Pringy, France.
  • Agape P; Hôpital Felix Guyon- Centre Hôpital Universitaire (CHU) de la Réunion, La Réunion, France.
  • Nicolini FE; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Varet B; Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes, Paris, France.
  • Gardembas M; CHU d'Angers, Angers, France.
  • Etienne G; Institut Bergonié, Bordeaux, France.
  • Réa D; Hôpital Saint-Louis, AP-HP, Paris, France.
  • Roy L; Institut National de la Sante' et de la Recherche Médicale (INSERM) Clinical Investigation Center (CIC) 802, CHU de Poitiers, Poitiers, France.
  • Escoffre-Barbe M; Centre Hospitalier Pontchaillou, Rennes, France.
  • Guerci-Bresler A; CHU Brabois Vandoeuvre, Nancy, France.
  • Tulliez M; Hôpital Henri Mondor, AP-HP, Paris, France.
  • Prost S; Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses, France.
  • Spentchian M; Hôpital Mignot, Le Chesnay, France.
  • Cayuela JM; Hôpital Saint-Louis, AP-HP, Paris, France.
  • Reiffers J; Institut Bergonié, Bordeaux, France.
  • Chomel JC; INSERM U935, Université Poitiers et Paris Sud 11, Le Kremlin-Bicêtre, France.
  • Turhan A; INSERM U935, Université Poitiers et Paris Sud 11, Le Kremlin-Bicêtre, France.
  • Guilhot J; INSERM CIC 802, CHU de Poitiers, Poitiers, France.
  • Guilhot F; INSERM CIC 802, CHU de Poitiers, Poitiers, France.
  • Mahon FX; INSERM U1035, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux, France.
J Clin Oncol ; 32(25): 2823-5, 2014 Sep 01.
Article em En | MEDLINE | ID: mdl-25071119
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Female / Humans / Male Idioma: En Revista: J Clin Oncol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Female / Humans / Male Idioma: En Revista: J Clin Oncol Ano de publicação: 2014 Tipo de documento: Article